Abstract
Ravulizumab (Ultomiris(R)), a humanized monoclonal antibody that inhibits complement protein C5, is indicated for the treatment of atypical haemolytic......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
